Navigation Links
Medical Device Developer Promaxo Closes $3.5 Million Series A Funding Round
Date:9/27/2017

Promaxo, Inc., a medical device company developing and commercializing a single-sided MRI, announced today that it has closed a $3.5 million Series A funding, with MicroPort Scientific Corporation as the strategic investor leading the round. As part of the strategic investment, MicroPort will secure exclusive China distribution rights and manufacturing rights of Promaxo’s MRI technology to support China commercialization.

Promaxo will use the new capital, together with $1.4 million in seed funding raised earlier this year, to perform clinical validation and prepare regulatory submission of its office-based high-resolution MRI. The Company’s MRI platform is protected by 33 issued and pending patents, and has been awarded over $9 million in NIH and NSF grants.

Once brought to market, Promaxo’s suite of prostate cancer disease management solutions will transform the screening, diagnosis and treatment of prostate cancer, and improve the lives of millions of men affected by the disease. A video highlighting the Promaxo story and solution is available at: https://youtu.be/AnGAwM2LlkQ

“We are thrilled to have MicroPort on board as a strategic investor and partner,” stated Promaxo’s CEO and President Amit Vohra, PhD, MBA. “The partnership will allow us to leverage MicroPort’s brand, talents, and global footprint to scale Promaxo’s MRI platform, and bring an office-based MRI to the masses.”

In a separate but related announcement, as part of its strategic growth plan, Promaxo has recently added Diego Olego, PhD, MBA, to the Company’s advisory team. Dr. Olego joined Philips in 1986, and over a career spanning more than three decades held several leadership positions in research, technology and innovation management, including Chief Strategy and Innovation Officer of Philips Healthcare.

"I am excited to be joining the Promaxo team,” stated Dr. Olego. “I believe that Promaxo's mobile innovative MR platform promises broad clinical and workflow impact, especially for prostate cancer patients."

For more information visit http://www.promaxo.com or email hello(at)promaxo.com.

About Promaxo Inc.

Promaxo is developing and commercializing office-based high-resolution MRI, real time MRI compatible biopsy and treatment tools, and CAD software for tissue characterization. The company is currently focused on transforming the screening, diagnosis and treatment of prostate cancer.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14733715.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. In’Tech Medical Unveils New Branding Initiative
2. Velico Medical Announces a Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma
3. Vixiar Medical Taking up Residence at The LaunchPort™ in Port Covington
4. Varicose Veins Myths Highlight the Importance of Understanding Medical Options, says Northwest Vein & Aesthetic Center
5. Pacific Neuroscience Institute Medical Group Joins Providence Saint Johns Health Clinic For Greater Access to Care of Neurological and Cranial Disorders
6. Novel Medical Device Manufacturing Operation and Accelerator Coming to Port Covington
7. Omnia Education Expands its Live Medical Conferences by Adding New U.S. Cities, New Faculty, Interactive Educational Games, and Cutting Edge Clinical Topics
8. CNA Finance Initiates Research Coverage On Advanced Medical Isotope Corporation
9. Brian Pogue Named Editor of Journal of Biomedical Optics
10. Lutheran Medical Center Recognized in Fierce Innovation Awards in Healthcare for its Implementation of BIOVIGIL
11. Kapstone Medical Celebrates 10th Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... October 09, 2019 , ... ... Montgomery County middle school and high school students have improved neuro-cognitive executive skills ... techniques and physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping skills, ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
(Date:10/3/2019)... ... October 02, 2019 , ... eKare’s inSight® digital 3D ... Health Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), the innovation ... technology in NHS by providing support to develop and deploy solutions to the most ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as one of ... MRSA becoming one of the most serious concerns. Hong Kong cannot be spared from ... MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the year the ...
Breaking Biology Technology:
(Date:10/4/2019)... ... October 03, 2019 , ... Mount Sinai researchers have discovered how the enzyme ... generation to the next. In a study published in Nature Structural & Molecular Biology, ... leading to cancers and other diseases. , “DNA polymerase delta serves as the duplicating ...
(Date:9/30/2019)... ... September 30, 2019 , ... Foresight Institute, a ... other transformative technologies, announced the winners for the 2019 Foresight Institute Feynman Prizes. ... Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named in honor of ...
(Date:9/30/2019)... Calif. (PRWEB) , ... September ... ... a leading think tank, research, and public interest organization focused on molecular ... Distinguished Student Prize. , The Award recognizes the College graduate or undergraduate ...
Breaking Biology News(10 mins):